151 related articles for article (PubMed ID: 20307913)
1. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
[TBL] [Abstract][Full Text] [Related]
2. Different epidermal growth factor receptor gene mutations in a patient with 2 synchronous lung cancers.
Nakano H; Soda H; Nakamura Y; Uchida K; Takasu M; Nakatomi K; Izumikawa K; Hayashi T; Nagayasu T; Tsukamoto K; Kohno S
Clin Lung Cancer; 2007 Nov; 8(9):562-4. PubMed ID: 18186961
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
Matsuzoe D; Hideshima T; Ohshima K; Kawahara K; Shirakusa T; Kimura A
Br J Cancer; 1999 Mar; 79(9-10):1549-52. PubMed ID: 10188905
[TBL] [Abstract][Full Text] [Related]
4. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
5. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
6. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report.
Jin B; Zhang S; Chuang X; Yu P; Chen Y; Teng Y; Che X; Fan Y; Zheng C; Li X; Qiu X; Qu X; Liu Y
BMC Cancer; 2018 Nov; 18(1):1138. PubMed ID: 30453894
[TBL] [Abstract][Full Text] [Related]
8. Late breast metastasis from resected lung cancer diagnosed by epidermal growth factor receptor gene mutation.
Fukumoto K; Usami N; Okasaka T; Kawaguchi K; Okagawa T; Suzuki H; Yokoi K
Lung Cancer; 2011 Nov; 74(2):352-3. PubMed ID: 21944773
[TBL] [Abstract][Full Text] [Related]
9. Mutations of epidermal growth factor receptor of non-small cell lung cancer were associated with sensitivity to gefitinib in recurrence after surgery.
Kondo M; Yokoyama T; Fukui T; Yoshioka H; Yokoi K; Nagasaka T; Imaizumi K; Kume H; Hasegawa Y; Shimokata K; Sekido Y
Lung Cancer; 2005 Dec; 50(3):385-91. PubMed ID: 16140420
[TBL] [Abstract][Full Text] [Related]
10. L858R EGFR mutation status correlated with clinico-pathological features of Japanese lung cancer.
Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Lung Cancer; 2006 Oct; 54(1):103-8. PubMed ID: 16890322
[TBL] [Abstract][Full Text] [Related]
11. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
[TBL] [Abstract][Full Text] [Related]
12. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
13. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers.
Chang YL; Wu CT; Lin SC; Hsiao CF; Jou YS; Lee YC
Clin Cancer Res; 2007 Jan; 13(1):52-8. PubMed ID: 17200338
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
[TBL] [Abstract][Full Text] [Related]
15. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer.
Tomizawa Y; Iijima H; Sunaga N; Sato K; Takise A; Otani Y; Tanaka S; Suga T; Saito R; Ishizuka T; Dobashi K; Minna JD; Nakajima T; Mori M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6816-22. PubMed ID: 16203769
[TBL] [Abstract][Full Text] [Related]
17. Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung.
Kozuki T; Hisamoto A; Tabata M; Takigawa N; Kiura K; Segawa Y; Nakata M; Mandai K; Eguchi K; Ueoka H; Tanimoto M
Lung Cancer; 2007 Oct; 58(1):30-5. PubMed ID: 17561305
[TBL] [Abstract][Full Text] [Related]
18. Two lung adenocarcinomas in the same lobe: multiple primaries or intrapulmonary metastasis?
Yoshimoto K; Yoshida J; Ishii G; Nishimura M; Hishida T; Nagai K
Ann Thorac Cardiovasc Surg; 2011; 17(6):584-7. PubMed ID: 21881358
[TBL] [Abstract][Full Text] [Related]
19. EGFR Mutation status in Japanese lung cancer patients: genotyping analysis using LightCycler.
Sasaki H; Endo K; Konishi A; Takada M; Kawahara M; Iuchi K; Matsumura A; Okumura M; Tanaka H; Kawaguchi T; Shimizu T; Takeuchi H; Yano M; Fukai I; Fujii Y
Clin Cancer Res; 2005 Apr; 11(8):2924-9. PubMed ID: 15837743
[TBL] [Abstract][Full Text] [Related]
20. High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma.
Moiseyenko VM; Procenko SA; Levchenko EV; Barchuk AS; Moiseyenko FV; Iyevleva AG; Mitiushkina NV; Togo AV; Semionov II; Ivantsov AO; Matsko DE; Imyanitov EN
Onkologie; 2010; 33(5):231-8. PubMed ID: 20502057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
